TabsDetailsBasic DetailsDate: Wednesday, August 28, 2019Type: PresentationMedical Product: biosimilar, filgrastim, infliximabMaterials: Biosimilar Use in the United States: A Sentinel Analysis of Filgrastim and InfliximabAdditional InformationInformationHost: 35th International Conference on Pharmacoepidemiology & Therapeutic Risk ManagementRelated Assessment(s): Abstracts of the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Pennsylvania Convention Center, Philadelphia, PA, USA, August 24‐28, 2019Investigation of Nonproprietary Name Suffix Use for Biologics and BiosimilarsUnderstanding Utilization Patterns of Biologics and Biosimilars in the United States to Support Postmarketing Studies of Safety and EffectivenessContributorsAuthor(s): Sarah K. Dutcher, Efe Eworuke, Elnara Fazio-Eynullayeva, Elizabeth Dee, Michael D. Nguyen, Catherine A. Panozzo
